SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-18-006346
Filing Date
2018-09-24
Accepted
2018-09-21 19:33:27
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B4 a2236756z424b4.htm 424B4 2309480
2 G965634.JPG g965634.jpg GRAPHIC 25609
3 G248225.JPG g248225.jpg GRAPHIC 110081
4 G1007614.JPG g1007614.jpg GRAPHIC 24299
5 G240375.JPG g240375.jpg GRAPHIC 92066
6 G174308.JPG g174308.jpg GRAPHIC 117388
7 G1041457.JPG g1041457.jpg GRAPHIC 30873
8 G581875.JPG g581875.jpg GRAPHIC 16062
9 G276437.JPG g276437.jpg GRAPHIC 41380
10 G928721.JPG g928721.jpg GRAPHIC 60863
11 G227595.JPG g227595.jpg GRAPHIC 28814
12 G334356.JPG g334356.jpg GRAPHIC 27649
13 G65810.JPG g65810.jpg GRAPHIC 192634
14 G699236.JPG g699236.jpg GRAPHIC 128778
  Complete submission text file 0001047469-18-006346.txt   3547103
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-226999 | Film No.: 181082456
SIC: 2834 Pharmaceutical Preparations